McAdam, LLC Q1 2022 Filing

Filed April 7, 2022

Portfolio Value

$1.1T

Holdings

213

Report Date

Q1 2022

Filing Type

13F-HR

All Holdings (213 positions)

#StockSharesValue% PortfolioType
201
SOXXISHARES TR
434$205.0M0.02%
202
BXBLACKSTONE INC
1,607$204.0M0.02%
203
XLKSELECT SECTOR SPDR TR
1,274$202.0M0.02%
204
GAMIDA CELL LTD
25,629$106.0M0.01%
205
LPTXEURLEAP THERAPEUTICS INC
48,885$86.0M0.01%
206
HEPION PHARMACEUTICALS INC
62,169$80.0M0.01%
207
T2 BIOSYSTEMS INC
113,201$59.0M0.01%
208
PYREURPYROGENESIS CDA INC
21,130$53.0M0.01%
209
SENS1GBPSENSEONICS HLDGS INC
25,001$49.0M0.00%
210
VSTMVERASTEM INC
31,055$44.0M0.00%
211
DESKTOP METAL INC
34,541$40.0M0.00%Call
212
SNDLEURSUNDIAL GROWERS INC
11,230$8.0M0.00%
213
CRBPEURCORBUS PHARMACEUTICALS HLDGS
10,006$5.0M0.00%
PreviousPage 3 of 3